MADRIGAL PHARMACEUTICALS, INC. 4/A
4/A · MADRIGAL PHARMACEUTICALS, INC. · Filed Nov 4, 2016
Insider Transaction Report
Form 4/AAmended
MILLIGAN DAVID V
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-07-22+20,000→ 20,000 totalExercise: $9.45Exp: 2026-07-22→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]This report amends the original report to reflect the correct exercise price of $9.45 per share.
- [F2]Fifty percent (50%) of the option vests on July 22, 2017 and thereafter it vests at a rate of twelve and one-half percent (12.5%) per quarter for four (4) consecutive quarters.